The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Analysts say Eli Lilly may have a future blockbuster drug on its hands: An experimental pill designed to lower ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno ...
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug ... Zepbound should be used in combination with a reduced-calorie diet and increased physical activity, the ...
Eli Lilly & Co. Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by ...
CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
Eli Lilly CEO David Ricks joins 'Squawk on the Street' to discuss the company's drug pipeline, 2025 outlook, state of the ...